Title: Raymund Buhmann - Innovator in Cancer Treatment
Introduction
Raymund Buhmann is an inventor based in Diessen am Ammersee, Germany. He is currently associated with Lindis Biotech GmbH, where he focuses on innovative approaches to cancer treatment. Although he has not yet been granted any patents, his work in the field of bispecific antibodies shows great promise.
Latest Patent Applications
Raymund Buhmann's notable patent application is titled "Subcutaneously Administered Bispecific Antibodies for Use in the Treatment of Cancer." This invention relates to the use of T cell redirecting, bispecific, particularly trifunctional, antibodies for treating cancer. The application highlights that administering the antibody via the subcutaneous route reduces the release of proinflammatory cytokines while substantially suppressing the release of inhibitory cytokines. Furthermore, this treatment may be combined with other anti-cancer drugs for enhanced efficacy.
Conclusion
Raymund Buhmann is making significant strides in the field of cancer treatment through his innovative research and applications. His work with bispecific antibodies has the potential to improve therapeutic outcomes for cancer patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.